PRZOOM - /newswire/ -
Philadelphia, PA, United States, 2010/12/22 - The third annual Ubiquitin Drug Discovery & Diagnostics conference will be held in Philadelphia from July 11th to 13th, 2011 and will bring together ubiquitin experts from academia and industry - UbiquitinConference.com.
The upcoming 2011 Ubiquitin Drug Discovery & Diagnostics Conference, to be held next year in Philadelphia from July 11th to the 13th, marks the third-annual landmark gathering of ubiquitin-focused professionals from academia and industry.
Building on the success of the 2009 and 2010 events, this premier conference in ubiquitin research and its application to the treatment of human disease host an international gathering of academic, industry and government professionals.
The three-day conference and workshop is unique in its focus on drug discovery within the ubiquitin pathway, and in its balance of both industry and academic interests. Delegates will have the opportunity to participate in a series of roundtable discussions and poster sessions, and to network with like-minded researchers from around the world.
The program will begin with an innovative pre-conference workshop covering various topics in assays and assay platforms, substrate identification, and ubiquitylation. The focus will be on technical advances in ubiquitin research and its application to the treatment of human disease.
Keynote speakers for the main conference include Millennium Pharmaceuticals' Chief Scientific Officer Joseph Bolen and.Keith Wilkinson, Professor of Biochemistry at Emory University. The conference program will cover topics in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting.
Those interested in attending the conference should register as soon as possible to secure their attendance and accommodation – discounted rates at the Four Seasons Hotel are available for delegates on a first-come, first-serve basis.